SCHEMBL3876033

SCHEMBL3876033

Fc1ccccc1-c1nc(N2CCOCC2)nc(N2CCN(c3ccccn3)CC2)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.50
HSD17B10 Q99714 3/20 0.50
ALDH1A1 P00352 3/20 0.50
KDM4E B2RXH2 3/20 0.50
POLB P06746 1/20 0.49
CNR2 P34972 1/20 0.47
MAPK1 P28482 2/20 0.47
STK4 Q13043 1/20 0.45
STK3 Q13188 1/20 0.45
LRRK2 Q5S007 1/20 0.45
NPC1 O15118 1/20 0.44
HK1 P19367 1/20 0.44
RAB9A P51151 1/20 0.44
HKDC1 Q2TB90 1/20 0.44
PIK3CA P42336 5/20 0.44
MTOR P42345 5/20 0.44
PIK3R1 P27986 3/20 0.44
LMNA P02545 2/20 0.44
RICTOR Q6R327 1/20 0.44
RPTOR Q8N122 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3885540 0.89 BCHE (0.49) HPGDHSD17B10ALDH1A1KDM4EPOLB
SCHEMBL3878479 0.89 BCHE (0.57) HPGDHSD17B10ALDH1A1KDM4EPOLB
SCHEMBL3878768 0.87 HPGD (0.47) HPGDHSD17B10ALDH1A1KDM4EPOLB
SCHEMBL3599909 0.86 PIK3CA (0.50) HPGDHSD17B10ALDH1A1KDM4ECNR2
SCHEMBL3876798 0.86 PIK3CA (0.50) HPGDHSD17B10ALDH1A1KDM4ECNR2
SCHEMBL3878604 0.85 ALDH1A1 (0.52) HPGDHSD17B10ALDH1A1KDM4ECNR2
SCHEMBL3879522 0.84 HSD17B10 (0.52) HPGDHSD17B10ALDH1A1KDM4EMAPK1
SCHEMBL3887621 0.83 PIK3CA (0.58) HPGDHSD17B10ALDH1A1KDM4EPIK3CA
SCHEMBL3877695 0.82 PIK3CA (0.48) HPGDHSD17B10ALDH1A1KDM4EPOLB
SCHEMBL3880853 0.82 ALDH1A1 (0.50) HPGDHSD17B10ALDH1A1KDM4EMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7566712-B2 Biaryl piperazinyl-pyridine analogues NEUROGEN CORPORATION (US) 2009-07-28 US disclosed
US-7566712-B2 Biaryl piperazinyl-pyridine analogues NEUROGEN CORPORATION (US) 2009-07-28 US disclosed
US-7566712-B2 Biaryl piperazinyl-pyridine analogues NEUROGEN CORPORATION (US) 2009-07-28 US disclosed
US-20070027155-A1 Biaryl piperazinyl-pyridine analogues NEUROGEN CORPORATION 2007-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070027155-A1 Biaryl piperazinyl-pyridine analogues GPR174, GPR68, PPARG HPGD 952/4885HSD17B10 3040/4885ALDH1A1 920/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.